[28] found that the co‐occurrence of SF3B1 with TET2 had a similar prognosis compared to the single SF3B1 mutation, suggesting the effect of the TET2 mutation on the prognosis of SF3B1mut MDS was minimal. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.